Orally administered 5-aminolevulinic acid for isolation and characterization of circulating tumor-derived extracellular vesicles in glioblastoma patients

• S. Maas,
• T.S. van Solinge,
• R. Schnoor,
• A. Yekula,
• J. Senders,
• J. de Vrij,
• P. Robe,
• B. Carter,
• L. Balaj,
• G. Arkesteijn,
• E. Nolte-'t Hoen,
• M. Broekman

Affiliations

S. Maas

University Medical Centre Utrecht, Neurosurgery, Utrecht, Netherlands; University Medical Centre Utrecht, Pathology, Utrecht, Netherlands

T.S. van Solinge

Massachusetts General Hospital, Neurology, Charlestown, United States; Leiden University Medical Centre, Neurosurgery, Leiden, Netherlands

R. Schnoor

University Medical Centre Utrecht, Neurosurgery, Utrecht, Netherlands

A. Yekula

Massachusetts General Hospital, Neurosurgery, Boston, United States

J. Senders

University Medical Centre Utrecht, Neurosurgery, Utrecht, Netherlands

J. de Vrij

Erasmus Medical Centre, Neurosurgery, Rotterdam, Netherlands

P. Robe

University Medical Centre Utrecht, Neurosurgery, Utrecht, Netherlands

B. Carter

Massachusetts General Hospital, Neurosurgery, Boston, United States

L. Balaj

Massachusetts General Hospital, Neurosurgery, Boston, United States

G. Arkesteijn

Utrecht University, Faculty of Veterinary Medicine, Utrecht, Netherlands

E. Nolte-'t Hoen

Utrecht University, Faculty of Veterinary Medicine, Utrecht, Netherlands

M. Broekman

Leiden University Medical Centre, Neurosurgery, Leiden, Netherlands; Haaglanden Medical Centre, Neurosurgery, Den Haag, Netherlands; Massachusetts General Hospital, Neurology, Charlestown, United States